the mortality and the need for artificial ventilation. The main side effects encountered were severe drowsiness, coma, and apnoeic episodes which reduced.
Neonatal tetanus has a high mortality and is a serious problem in developing countries. Diazepam has powerful muscle relaxing and anticonvulsant properties and has been used in conventional dosage (2-13 mg/kg per day) to treat neonatal tetanus, but this has had little effect on mortality (Hendrickse and Sherman, 1966; Oduori, 1974) . We report our experience with high dose diazepam in the management of neonatal tetanus.
Patients and methods
Nineteen consecutive cases of neonatal tetanus were admitted to this hospital between January 1974 and June 1977. The diagnosis was clinical, any neonate presenting with at least 3 of the following was included in the study: trismus, risus sardonicus, muscular rigidity, and spasms of voluntary muscles. Lumbar puncture was performed and blood glucose, calcium, and magnesium levels were determined in most patients. The severity of the illness was graded according to the criteria of Patel and Joag (1959) , ,one point being awarded to each of the following: (a) inability to suck, (b) presence of muscular spasms, (c) rectal temperature > 38°C within 24 hours of admission, (d) incubation period < 7 days, (e) onset -of spasms occurring within 48 hours after the first symptom. All the patients had severe tetanus (grades 4 and 5).
General care. On admission a peripheral intravenous infusion with 5% dextrose in 0.18% saline was set up. An initial slow bolus IV injection of 2 mg ,increasing to 10 mg diazepam was administered to relieve muscular spasms and rigidity. The neonate Received 31 January 1978 were reversible when the level of diazepan was was nursed in an incubator in the open paediatric ward; the pulse and respiratory rate, colour, and frequency and severity of muscular spasms were closely monitored. Particular care was paid to clearing the nasopharynx of secretions.
Antibiotics, tetanus antitoxin, and toxoid. The umbilical cord, if infected, was excised and the umbilicus cleaned with hydrogen peroxide and surgical spirit. All patients received 1500 to 5000 units of equine antitetanus serum, and IV crystalline penicillin (100 000 units kg/per day) was given for 7 days. Active immunisation was started before discharge.
Feeding. During the first 24 hours the daily fluid and electrolyte requirements were administered intravenously as the risk of aspiration from uncontrolled spasms was greatest during this period. Thereafter, nasogastric milk feeding was introduced and the amount gradually increased. In most cases nasogastric feeding was fully established by the 5th to 7th day, the IV drip being continued only for the administration of drugs. However in 7 patients nasogastric feeding was not tolerated and nutrition was provided by peripheral intravenous hyperalimentation.
Sedation. Muscle relaxation and sedation were achieved by continuous IV infusion of high dose diazepam (20-40 mg/kg per day) and intragastric phenobarbitone (10-15 mg/kg per day in 4 divided doses). The initial total daily maintenance dose of diazepam was 20 mg/kg and this could be increased gradually to a maximum of 40 group.bmj.com on November 8, 2017 -Published by http://adc.bmj.com/ Downloaded from and cyanosis while on IPPV. The neurological sequelae seem unlikely to be the result of treatment with diazepam because these children were still having frequent muscle spasms in spite of the high dose of diazepam.
Discussion
Diazepam is a potent tranquilliser, anticonvulsant, and muscle relaxant. Although the site and mechanism of its action are still incompletely understood, it has been shown to block spinal reflexes in anaesthetised cats (Randal et al., 1961) . Hendrickse and Sherman (1966) first reported the use oforal diazepam (up to 4-4 mg/kg per day) in a controlled study of 104 cases of neonatal tetanus. They concluded that although the mortality rate (55 Y.) was unaffected by diazepam, it was of value in relaxing tonic muscle spasms; moreover it was relatively free of unpleasant side effects or toxicity. There has been only one report of the use of high dose diazepam (40 mg/kg per day) in the successful treatment of a patient with neonatal tetanus (Femi-Pearse, 1966) .
From 1969 to 1973, we treated 43 cases of neonatal tetanus (89% of whom were grade 4 and 5 severity) with conventional dose IV diazepam (2-10 mg/kg per day divided into 4 doses) and nasogastric phenobarbitone (5-15 mg/kg per day divided into 4 doses). The result was disappointing as 77% of those patients subsequently required IPPV because of failure to control the spasms (Lee et al., 1978) . In the present series, only 7 (37%) of 19 patients required IPPV. The severity of the disease in the present group was similar to the 1969-73 group (100 and 89% respectively falling into the severe grades). In our experience, increasing the dosage of diazepam above 40 mg/kg per day did not appreciably reduce the need for subsequent respiratory support, as 6 of the 7 patients requiring more than 40 mg/kg per day needed IPPV (Table) .
The main side effects encountered with this regimen were severe drowsiness, coma, and occasionally apnoeic episodes which were reversible when the dose of the drug was reduced. These patients tended to have excessive pooling of secretions in the oropharynx because the swallowing reflex was depressed, and they required frequent suction. Respiratory arrest is another potential hazard, but the continuous infusion of diazepam did not seriously depress respiration. Renal, hepatic, and haematological functions were also unaffected.
Although diazepam forms a white precipitate when diluted with dextrose saline solutions, this does not result in any adverse reaction nor does it reduce the therapeutic potency (Smith and Masotti, 1971) . However, the solvent of diazepam contains 5 % sodium benzoate which competes with bilirubin for the binding sites in albumin, thus increasing the risks of hyperbilirubinaemia (Schiff et al., 1971) . Hyperbilirubinaemia was not a problem as most of our patients were term infants and more than 7 days old at admission. In this series only 3 developed neonatal jaundice; the maximum total bilirubin levels reached were 8*5, 10*8, and (Case 15) 18*2 mg/ 100 ml respectively. Case 15 was treated with phototherapy and serum bilirubin fell to 10*8 mg/ 100 ml 4 days later; unfortunately this patient was lost to follow-up. During intravenous diazepam treatment, care was taken to ensure that the percutaneous intravenous needle was not dislodged as skin necrosis can result from subcutaneous perfusion of the drug. 
